Skip to main content
logo
Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.9800
+0.0500 (5.38%)
Nov 2, 2026, 3:48 PM HKT

HKG:2185 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
38.4544.93----
Revenue Growth
-14.43%-----
Gross Profit
15.0418.02----
Operating Income
-88-71.69-61.04-164.62-252.2-409.65
Net Income
-75.5-70.05-87.94-175.89-204.24-361.45
Earnings Per Share
-0.31-0.29-0.36-0.72-0.84-1.64
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
237.88248.52202.39369.44451.32708.53
Total Debt
11.5312.738.281.7618.1122.45
Net Cash (Debt)
226.35235.8194.1367.68433.21686.09
Net Cash Growth
-4.01%21.48%-47.21%-15.13%-36.86%51.67%
Net Cash Per Share
0.930.970.801.511.783.11

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-71.58-67.67-118.44-49.03-140.62-88.47
Capital Expenditures
-9.77-7.64-47.14-17.72-30.04-34.27
Free Cash Flow
-81.35-75.3-165.58-66.74-170.65-122.75
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
39.13%40.10%----
Operating Margin
-228.87%-159.56%----
Pretax Margin
-265.19%-213.66%----
Profit Margin
-196.37%-155.91%----
FCF Margin
-211.59%-167.59%----

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.3728.19----